Recursion prices $200M stock offering as Sanofi picks partnered drug candidate
Recursion has priced a $200 million stock offering. Separately, partner Sanofi has selected a drug candidate from their collaboration.
Recursion has priced a $200 million stock offering. Separately, partner Sanofi has selected a drug candidate from their collaboration.
MTN has secured a $2.34 million NIH Fast Track grant to advance technology that maps relationships across fragmented data systems. The company sees uses in healthcare and other data-intensive industries.
Four geothermal projects across New Mexico have received more than $17 million in state funding to evaluate potential hot spots. Results are expected next year, and promising data could lead private developers to plan more geothermal plants, according to a top state energy official.